Art-Based Emotion Regulation Program
ConditionChildren With Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-18
SponsorGazi University
About this trial
Adolescents receiving cancer treatment often experience increased anxiety, difficulties in emotion regulation, and a high symptom burden due to treatment-related physical effects and psychosocial stressors. Supportive, non-pharmacological interventions that promote emotional regulation are therefore needed.
The purpose of this randomized controlled trial is to evaluate the effect of an art-based emotion regulation program on anxiety levels, emotion regulation skills, and symptom burden in adolescents undergoing cancer treatment.
This single-blind, parallel-group randomized controlled study will include 60 adolescents aged 10-18 years receiving cancer treatment at Gazi University Health Application and Research Center and Etlik City Hospital Pediatric Hematology-Oncology units between January 30, 2026 and March 20, 2027. Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a 4-week art-based emotion regulation program, while the control group will receive routine care. Outcomes will be assessed using validated self-report measures at baseline and at the end of the intervention period.
Eligibility criteria
Qualifiers
Receiving cancer treatment for at least 6 months,
Aged between 10 and 18 years,
The participant and their parent/guardian consent to participate in the study and provide written informed consent.
Disqualifiers
Those who have experienced a significant life event (death, relocation, etc.) unrelated to their illness in the last six months,
Those who have not received chemotherapy treatment,
Those in the terminal stage,
Those with a severe psychological diagnosis and taking medication
Trial design
Treatments tested in this trial
- Art-Based Emotion Regulation Program
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov